These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1694251)

  • 1. Endoscopic balloon dilation of the prostate: early experience.
    Goldenberg SL; Perez-Marrero RA; Lee LM; Emerson L
    J Urol; 1990 Jul; 144(1):83-7; discussion 87-8. PubMed ID: 1694251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year.
    Thalmann GN; Graber SF; Bitton A; Burkhard FC; Gruenig O; Studer UE
    J Urol; 1999 Aug; 162(2):387-93. PubMed ID: 10411044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation.
    Gill KP; Machan LS; Allison DJ; Williams G
    Br J Urol; 1989 Dec; 64(6):618-22. PubMed ID: 2483354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transurethral balloon laser thermotherapy for symptomatic benign prostatic hyperplasia: preliminary clinical results.
    Furuya S; Tsukamoto T; Kumamoto Y; Daikuzono N; Liong ML
    J Endourol; 1995 Apr; 9(2):145-9. PubMed ID: 7543325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy.
    Javlé P; Jenkins SA; West C; Parsons KF
    J Urol; 1996 Sep; 156(3):1014-8; discussion 1018-9. PubMed ID: 8709299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
    Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
    Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia.
    Lepor H; Sypherd D; Machi G; Derus J
    J Urol; 1992 Mar; 147(3):639-42; discussion 642-4. PubMed ID: 1371550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
    Steele GS; Sleep DJ
    J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia.
    Erol A; Cam K; Tekin A; Memik O; Coban S; Ozer Y
    J Urol; 2009 Sep; 182(3):1078-82. PubMed ID: 19616811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of catheter size on urodynamic assessment of bladder outlet obstruction.
    Klausner AP; Galea J; Vapnek JM
    Urology; 2002 Nov; 60(5):875-80. PubMed ID: 12429319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results.
    Thalmann GN; Mattei A; Treuthardt C; Burkhard FC; Studer UE
    J Urol; 2002 Jun; 167(6):2496-501. PubMed ID: 11992066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.
    Kaplan SA; Te AE
    Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.